INFECTION OF PATIENTS WITH LIVER TRANSPLANTATION WITH COVID-19

INFECTION OF PATIENTS WITH LIVER TRANSPLANTATION WITH COVID-19

Authors

  • RUSLAN BOLKVADZE
  • KAKHABER KASHIBADZE
  • ZURAB CHOMAKHASHVILI
  • TAMAR MKHATVARI

DOI:

https://doi.org/10.52340/jecm.2022.06.004

Keywords:

Liver, Transplantation, Covid-19, immunosuppressive drugs

Abstract

The authors studied how COVID-19 is administered to liver transplant patients and found out that a mechanism to reduce virus virulence in infected liver transplant patients involves the use of immunosuppressant medications, to reduce the cytotoxic strain of the virus during this period. However, in the 21 patients we studied, it was clear that this contingent was constantly receiving immunosuppressive drugs, so they easily went through a period of COVID-19 infection.

Downloads

Download data is not yet available.

References

Hepatology International (2020) 14(4) 429-431;

American Journal of Transplantation (2021) 21(6) 2279-2284;

Transplant Infectious Disease (2021);

The Lancet Gastroenterology and Hepatology (2021);

Journal of Gastrointestinal Surgery (2021);

Journal of Clinical and Experimental Hepatology (2021);

Journal of Clinical Gastroenterology (2021);

United European Gastroenterology Journal (2021);

Downloads

Published

2022-09-06

How to Cite

BOLKVADZE, R. ., KASHIBADZE, K. ., CHOMAKHASHVILI, Z. ., & MKHATVARI, T. . (2022). INFECTION OF PATIENTS WITH LIVER TRANSPLANTATION WITH COVID-19. Experimental and Clinical Medicine Georgia, (6). https://doi.org/10.52340/jecm.2022.06.004

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.

Loading...